title: Effects of group-home care on behavioral symptoms, quality of life, and psychotropic drug use in patients with frontotemporal dementia.
authors.forename: Osamu
authors.initials: O
authors.lastname: Yokota
authors.forename: Yoshikatsu
authors.initials: Y
authors.lastname: Fujisawa
authors.forename: Jun
authors.initials: J
authors.lastname: Takahashi
authors.forename: Seishi
authors.initials: S
authors.lastname: Terada
authors.forename: Takeshi
authors.initials: T
authors.lastname: Ishihara
authors.forename: Hanae
authors.initials: H
authors.lastname: Nakashima
authors.forename: Etsuko
authors.initials: E
authors.lastname: Oshima
authors.forename: Aki
authors.initials: A
authors.lastname: Kugo
authors.forename: Toshie
authors.initials: T
authors.lastname: Ata
authors.forename: Hideki
authors.initials: H
authors.lastname: Ishizu
authors.forename: Shigetoshi
authors.initials: S
authors.lastname: Kuroda
authors.forename: Ken
authors.initials: K
authors.lastname: Sasaki
mesh_terms: D000368:Aged; D003704:Dementia / Q000150:complications / Q000517:prevention & control / Q000523:psychology; D015577:Geriatric Assessment; D016352:Group Homes / Q000458:organization & administration*; D006272:Health Facility Environment; D006707:Homes for the Aged / Q000458:organization & administration; D006801:Humans; D007374:Interior Design and Furnishings; D001523:Mental Disorders / Q000209:etiology / Q000517:prevention & control*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D011788:Quality of Life; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D011619:Psychotropic Drugs